Chitosan sulfate inhibits angiogenesisviablocking the VEGF/VEGFR2 pathway and suppresses tumor growthin vivo
- 15 January 2019
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Biomaterials Science
- Vol. 7 (4) , 1584-1597
Abstract
Suppressing the angiogenesis in tumors by inhibiting the VEGF/VEGFR2 signaling pathway offers an important approach for cancer therapy. In this work, we developed a heparinoid angiogenesis inhibitor of sulphated chitosan (SCTS), which has a higher inhibitory activity and better safety compared with heparin. It can block the VEGF/VEGFR2 signaling pathway significantly and has a stronger inhibitory effect on the cellular migration and tube formation of HUVECs than heparin in the presence of VEGF in vitro as well. Other than this, SCTS showed an obvious inhibition in tumor size, which was 42.12% higher than the heparin group, and the results of immunohistochemistry showed that the inhibition rate of neovascularization in SCTS was significantly higher than for the heparin control (63.8% vs. 30.7%) at best. In addition, hemorrhage was never observed in the body during the entire process of the experiment, suggesting that it has no obvious anticoagulant activity and possesses good biocompatibility.Keywords
Funding Information
- National Natural Science Foundation of China (51273095, 51433004, 51773096)
- Natural Science Foundation of Tianjin Municipality (14JCQNJC03500, 17JCZDJC33500)
- Changjiang Scholar Program, Ministry of Education (IRT1257)
This publication has 57 references indexed in Scilit:
- AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis modelBMC Cancer, 2012
- Semaphorin signaling in angiogenesis, lymphangiogenesis and cancerCell Research, 2011
- Preactivation‐Based, One‐Pot Combinatorial Synthesis of Heparin‐like Hexasaccharides for the Analysis of Heparin–Protein InteractionsChemistry – A European Journal, 2010
- Multiple mechanisms for exogenous heparin modulation of vascular endothelial growth factor activityJournal of Cellular Biochemistry, 2010
- Morelloflavone, a Biflavonoid, Inhibits Tumor Angiogenesis by Targeting Rho GTPases and Extracellular Signal-Regulated Kinase Signaling PathwaysCancer Research, 2009
- Non-Anticoagulant Heparins and Inhibition of CancerPathophysiology of Haemostasis and Thrombosis, 2007
- Angiogenesis in life, disease and medicineNature, 2005
- Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivoNature, 1993
- The anticoagulant activity of heparin: Measurement and relationship to chemical structureJournal of Pharmaceutical and Biomedical Analysis, 1989
- Tumor Angiogenesis: Therapeutic ImplicationsNew England Journal of Medicine, 1971